Celltrion, Incorporation operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion, Incorporation with three other
companies in this sector in South Korea:
Samsung Biologics Co Ltd
sales of 294.62 billion Korean Won [US$260.45 million]
of which 100%
was Biological Medicine Production),
Green Cross Corporation
(1.20 trillion Korean Won [US$1.06 billion]
of which 86%
was Greencross), and
Celltrion HealthCare Co Ltd
(757.74 billion Korean Won [US$669.84 million]
Celltrion, Incorporation reported sales of 670.58 billion Korean Won (US$592.79 million)
December of 2016.
increase of 11.1%
versus 2015, when the company's sales were 603.41 billion Korean Won.
This was the third consecutive year of growth at Celltrion, Incorporation.
Sales of Chemical Business Division saw an increase
that was more than double the company's growth rate: sales were up
39.9% in 2016, from
72.58 billion Korean Won to 101.57 billion Korean Won.